Kristin Yarema, Chief Commercial Officer at Atara Biotherapeutics, Inc. (ATRA), bought 63,187 shares at $14.58 ($921K) on 2021-06-14, disclosed to the SEC on 2021-06-15.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.50 | 2,021 | $29K | 3.2% |
| 2 | $14.48 | 3,500 | $51K | 5.5% |
| 3 | $14.58 | 28,833 | $420K | 45.7% |
| 4 | $14.58 | 28,833 | $420K | 45.7% |
| Total | $14.57 avg | 63,187 | $921K | 100% |